20-Year Trends in Tobacco Sales and Self-Reported Tobacco Use in the United States, 2000-2020.


Journal

Preventing chronic disease
ISSN: 1545-1151
Titre abrégé: Prev Chronic Dis
Pays: United States
ID NLM: 101205018

Informations de publication

Date de publication:
28 07 2022
Historique:
entrez: 28 7 2022
pubmed: 29 7 2022
medline: 2 8 2022
Statut: epublish

Résumé

In the past 2 decades, many tobacco control policies were enacted, and several new or modified products were introduced into the US marketplace. Continued tobacco surveillance is critical in this evolving landscape. We examined 20-year trends in tobacco use from sales and self-reported data. We obtained data on taxable removals (sales) of cigarettes, cigars, roll-your-own (RYO) tobacco, and pipe tobacco from the US Department of the Treasury. We assessed self-reported past 30-day tobacco use from the National Survey on Drug Use and Health among people aged 18 years or older. Volume sales were standardized to cigarette packs and cigarette pack equivalents (CPEs) and trends measured by using joinpoint and logistic regression. From 2000 to 2019-2020, declines occurred in per capita sales of cigarettes (101.01 to 42.29 packs/capita), little cigars (0.54 to 0.03 CPEs/capita), and RYO tobacco (1.34 to 0.21 CPEs/capita). Volume sales also decreased for chewing tobacco and scotch/dry snuff (all P < .05). Conversely, volume sales increased for pipe tobacco, moist snuff, and snus for the respective assessed periods. Large cigar volume sales did not change significantly. We found consistent trends in self-reported use, except for RYO tobacco (decreased volume sales but increased self-reported use) and pipe smoking (increased volume sales, but trivial self-reported use <1% throughout the study period). Current use of any tobacco product decreased from 32.2% to 22.9% during the assessed period. Harmonizing the tax and regulatory structure within and across the diversity of tobacco products may help reduce aggregate tobacco consumption in the US.

Identifiants

pubmed: 35900882
doi: 10.5888/pcd19.210435
pii: E45
pmc: PMC9336190
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

E45

Références

Healthy People 2010 Stat Notes. 2002 Jul;(24):1-12
pubmed: 12117004
Am J Prev Med. 2022 Mar;62(3):341-349
pubmed: 34756629
Nicotine Tob Res. 2018 Nov 15;20(12):1457-1466
pubmed: 29059423
Tob Control. 2019 Jul;28(4):434-439
pubmed: 30120201
Nat Neurosci. 2003 Mar;6(3):309-15
pubmed: 12548289
Tob Control. 2020 Sep;29(5):537-547
pubmed: 31537629
Tob Control. 2015 Jun;24(e2):e125-7
pubmed: 24721968
MMWR Morb Mortal Wkly Rep. 2016 Dec 09;65(48):1357-1363
pubmed: 27932780
MMWR Morb Mortal Wkly Rep. 2012 Aug 3;61(30):565-9
pubmed: 22854624
Tob Control. 2020 Jul;29(4):412-419
pubmed: 31341001
Tob Control. 2018 Jan;27(1):99-104
pubmed: 28219975
Fed Regist. 2016 May 10;81(90):28973-9106
pubmed: 27192730
Nicotine Tob Res. 2018 May 3;20(6):698-706
pubmed: 28575408
Addiction. 2021 Oct;116(10):2859-2869
pubmed: 33788331
Tob Control. 2016 Jul;25(4):451-7
pubmed: 25899447
Tob Control. 2021 Feb 4;:
pubmed: 33542067
Nicotine Tob Res. 2020 May 26;22(6):942-949
pubmed: 31095329
Tob Control. 2020 May;29(3):269-276
pubmed: 31147473
PLoS One. 2012;7(5):e36487
pubmed: 22567159
Tob Control. 2020 Mar;29(2):175-182
pubmed: 30777880
Prev Med. 2014 Jun;63:13-9
pubmed: 24594102
JAMA. 2008 Jun 11;299(22):2629-30
pubmed: 18544722
MMWR Morb Mortal Wkly Rep. 2020 Feb 21;69(7):189-192
pubmed: 32078593
MMWR Morb Mortal Wkly Rep. 2020 Nov 20;69(46):1736-1742
pubmed: 33211681

Auteurs

Lungile Nkosi (L)

Sefako Makgatho Health Sciences University, Pretoria, South Africa.

Satomi Odani (S)

Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan.

Israel T Agaku (IT)

Harvard School of Dental Medicine, 188 Longwood Ave, Boston, MA 02115. Email: iagaku@post.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH